Gliclazide Krka

Gliclazide Krka is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. This antidiabetic agent helps control glucose levels when diet and exercise alone are insufficient.

Gliclazide Krka is primarily used to treat type 2 diabetes by lowering blood sugar levels. It works by stimulating the pancreas to produce more insulin, which helps the body use glucose more effectively. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise.

Common effects of Gliclazide Krka may include hypoglycemia, or low blood sugar, which can cause symptoms such as sweating, dizziness, and confusion. Other possible effects include nausea, headache, and weight gain. It is important to monitor blood sugar levels regularly while taking this medication.

Gliclazide Krka should be used with caution in patients with kidney or liver problems. It is important to follow the prescribed dosage and monitor blood sugar levels regularly. Patients should be aware of the signs of hypoglycemia and know how to treat it. This medication should not be used during pregnancy or breastfeeding unless advised by a healthcare professional.

Gliclazide Krka may interact with other medications, including other diabetes drugs, certain antibiotics, and some pain relievers. Alcohol can increase the risk of hypoglycemia and should be avoided. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.